YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.88
-0.27 (-4.39%)
Oct 7, 2026, 4:00 PM EDT - Market closed
YD Bio Market Cap
YD Bio has a market cap or net worth of $416.49 million as of October 7, 2026. That makes YD Bio the 16,159th most valuable company in the world and 2,906th in the United States. Its market cap has decreased by 67.46% in one year.
Market Cap
416.49M
Enterprise Value
413.83M
1-Year Change
-67.46%
Global Rank
Country Rank
#2,906 United States
Category
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $416.49M, an increase of 180.74%. That is a compound annual growth rate of 19.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 416.49M | -51.41% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 413.78M |
| Eikon Therapeutics | 410.03M |
| Atea Pharmaceuticals | 405.03M |
| Prelude Therapeutics | 388.29M |
| Zura Bio | 386.19M |
| Kyverna Therapeutics | 382.81M |
| Arcturus Therapeutics Holdings | 377.17M |
| vTv Therapeutics | 372.12M |